MPS Limited Q1 FY'27 Earnings Call Transcript Released
MPS Limited reported its strongest Q1 FY'27 with revenue at ₹224.24 crores (up 20.4%) and EBITDA at ₹76.96 crores (up 53.0%). The company reaffirmed its FY'27 EBITDA outlook to exceed ₹300 crores. Key segments like Research Solutions and Education showed robust growth, with a positive turnaround in Corporate Learning.
The announcement details strong quarterly financial results, significant year-over-year growth in revenue and EBITDA, and a confident future outlook. This information is highly material for investors and stakeholders.
The company reported strong financial results, exceeding previous performance metrics and reaffirming a positive financial outlook. Growth in revenue and EBITDA across key segments indicates a healthy business performance.
MPS Limited has released the transcript of its Earnings Conference Call held on July 22, 2026, to discuss the Un-Audited Financial Results for the First Quarter (Q1) ended June 30, 2026.
During the call, the company reported its strongest first quarter in history. Revenue for Q1 FY'27 was ₹224.24 crores, a 20.4% increase year-over-year. EBITDA grew by 53.0% to ₹76.96 crores, with the EBITDA margin expanding to 34.3% from 27.0% in the prior year. Profit after tax saw a significant rise of 43.0% to ₹50.39 crores, and basic EPS was ₹29.70, up from ₹20.78.
The company highlighted strong operating leverage, with headcount increasing by less than 3% while revenue grew 20% and EBITDA grew 53%. Excluding adjustments, underlying business revenue grew 28.4% and EBITDA grew 50.5%.
Research Solutions segment revenue grew 13.2% year-over-year to ₹123.23 crores, with EBITDA growing 37.9% and segment margin widening to 45.1%. The company is focusing on its AI-enabled production ecosystem, DigiCore, and Research Integrity Check.
Education segment revenue grew 42.2% year-over-year to ₹73.41 crores, with a 35.1% EBITDA margin, partly driven by the Unbound Medicine acquisition. The Corporate Learning segment showed a turnaround, with revenue growing 6.9% to ₹27.60 crores and EBITDA growing 60.7%, expanding the margin to 25.3% from under 17% a year ago.
MPS Limited reaffirmed its outlook to comfortably cross ₹300 crores in EBITDA for FY'27, viewing this as a floor rather than a ceiling. The company also discussed its strategic focus on AI, emphasizing its application in revenue generation rather than just presentation, and a significant shift towards outcome-based revenue models.
What to do with a filing like this
MPS Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by MPS Limited. Read the original for the full detail.